Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

MHC Mismatch Results in Neural Progenitor Cell Rejection Following Spinal Cord Transplantation in a Model of Viral-Induced Demyelination.
A small-molecule screen yields idiotype-specific blockers of neuromyelitis optica-immunoglobulin G binding to aquaporin-4.
Origin and differentiation of microglia.
History, applications, and mechanisms of deep brain stimulation.
"People power" or "pester power"? YouTube as a forum for the generation of evidence and patient advocacy.
Postpartum complicated by transverse myelitis.
Simvastatin inhibits secretion of Th17-polarizing cytokines and antigen presentation by DCs in patients with relapsing remitting multiple sclerosis.
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs.
Complement receptor-3 negatively regulates the phagocytosis of degenerated myelin through tyrosine kinase Syk and cofilin.
The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.
Callosal atrophy in multiple sclerosis is related to cognitive speed.
Case Studies: LAAM, Naltrexone, Clozapine, and Nicorette
Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.
Lack of neuroprotective effects of simvastatin and minocycline in a model of cervical spinal cord injury.
A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies
Regional anesthesia in patients with pre-existing neurologic disease.
Clinical Proton MR Spectroscopy in Central Nervous System Disorders.
Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease.
Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.
Use of Complementary and Alternative Medicine among People with Multiple Sclerosis in the Nordic Countries.
Pathogenic features of CD4(+)CD28(-) T cells in immune disorders.
Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis.
Serial electrophysiological findings in Guillain-Barré syndrome not fulfilling AIDP or AMAN criteria.
A new computerised cognitive test for the detection of information processing speed impairment in multiple sclerosis.
Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles.

Pages